The Biostatistics and Genetics Core (BGC) Component 2 will provide data processing, database coordination and maintenance, data analysis and statistical support for each of the other cores and projects within the Methamphetamine Abuse Research Center (MARC). Quantitative genetic analysis support will also be given to those Cores using mouse genetic models. This single unit serves as an important interface for the transmission of diverse types of data and processed information among core and project investigators. It assures that data and information from different cores and projects will be processed uniformly and in such a way as to allow for their smooth interface where appropriate. The environment provided by a single data management and biostatistics unit also facilitates the effective and timely return of processed data and information to the core and project investigators in support of their objectives. In addition, this Core will facilitate data sharing for investigators within and outside the center. This Core will continue to assist in the use of public databases and computer software, and provide the computer infrastructure for the microarray and QTL studies. Training in statistical and genetic methods and experimental design will also be provided on a one-on-one and as-needed basis. This Core will also develop new analytical programs tailored to the needs of MARC investigators, particularly newer clustering algorithms. As the Center continues to evolve, we will continue development of a central data warehouse for the MARC on our secure server.

Public Health Relevance

This Core supports the scientific activities of almost all other Cores and Components of the MARC, thus relevance stems from the impact of these other MARC units on the future mitigation or treatment of methamphetamine abuse in human drug abuse populations.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
2P50DA018165-06A1
Application #
8355293
Study Section
Special Emphasis Panel (ZDA1-EXL-T (02))
Project Start
Project End
Budget Start
2012-09-01
Budget End
2013-06-30
Support Year
6
Fiscal Year
2012
Total Cost
$280,143
Indirect Cost
$98,232
Name
Oregon Health and Science University
Department
Type
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Tosh, Dilip K; Ciancetta, Antonella; Mannes, Philip et al. (2018) Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists. ACS Omega 3:12658-12678
McCarty, Dennis; Priest, Kelsey C; Korthuis, P Todd (2018) Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities. Annu Rev Public Health 39:525-541
Eastwood, Emily C; Eshleman, Amy J; Janowsky, Aaron et al. (2018) Verification of a genetic locus for methamphetamine intake and the impact of morphine. Mamm Genome 29:260-272
Kohno, Milky; Dennis, Laura E; McCready, Holly et al. (2018) A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder. Drug Alcohol Depend 192:186-192
Holton, Dwight; White, Elizabeth; McCarty, Dennis (2018) Public Health Policy Strategies to Address the Opioid Epidemic. Clin Pharmacol Ther 103:959-962
Kohno, Milky; Loftis, Jennifer M; Huckans, Marilyn et al. (2018) The relationship between interleukin-6 and functional connectivity in methamphetamine users. Neurosci Lett 677:49-54
Shabani, Shkelzen; Schmidt, Bryan; Ghimire, Bikalpa et al. (2018) Depression-like symptoms of withdrawal in a genetic mouse model of binge methamphetamine intake. Genes Brain Behav :e12533
Eshleman, Amy J; Nagarajan, Shanthi; Wolfrum, Katherine M et al. (2018) Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters. Psychopharmacology (Berl) :
McCready, Holly; Kohno, Milky; Kolessar, Michael et al. (2018) Functional MRI and delay discounting in patients infected with hepatitis C. J Neurovirol 24:738-751
Loftis, Jennifer M; Valerio, Juno; Taylor, Jonathan et al. (2018) S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood-Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use Disorder. Alcohol Clin Exp Res :

Showing the most recent 10 out of 143 publications